The final inclusion of the speech therapy solution in the DiGA directory was based on the results a study in collaboration with Ludwig Maximilian University and the University of Applied Sciences and Arts in Göttingen. According to the study, Neolexon's aphasia app demonstrably helps those affected improve their language skills after a brain injury such as a stroke. Furthermore, the study showed that using the app improves the emotional health and quality of life of those affected.
The speech therapist and Neolexon co-founder Mona Späth commented:
"We are incredibly excited! Exactly ten years ago, my co-founder Hanna Jakob and I had the idea for this app – now it's clear: Neolexon Aphasia will be permanently reimbursed by all statutory health insurance providers. From the very beginning, our goal was to help those affected with a digital therapy that is proven effective and can be used by everyone with aphasia – regardless of their financial situation. This is a dream come true for us."
The Aphasia app is one of two digital speech therapy solutions with which Neolexon offers fully individualized therapy on a tablet or smartphone. Another app is aimed at children with impaired speech development. The apps accompany patients in parallel with their treatment with their speech therapist. According to the study results, the average usage time of the aphasia app was 31 minutes per day. Combined with standard on-site therapy, those affected achieved the recommended therapy duration of at least five hours per week. Due to an acute shortage of speech therapy places, the five hours are often not feasible without digital supplementation.
